Study finds acupuncture lowers hypertension by activating natural opioids
Researchers with the University of California, Irvine (UCI) Susan Samueli Center for Integrative Medicine have found that regular electroacupunture treatment can lower hypertension by increasing the release of a kind of opioid in the brainstem region that controls blood pressure.
In tests on rats, UCI cardiology researcher Zhi-Ling Guo and colleagues noted that reduced blood pressure lasted for at least three days after electroacupuncture by increasing the gene expression of enkephalins, which one of the three major opioid peptides produced by the body.
Their study, which appears in the Nature's Scientific Reports, presents the first evidence of the molecular activity behind electroacupunture's hypertension-lowering benefits.
Last year, the UCI team reported patients treated with acupuncture at certain wrist locations experienced drops in their blood pressure. The present study shows that repetitive electroacupuncture evokes a long-lasting action in lowering blood pressure in hypertension, suggesting that this therapy may be suitable for treating clinical hypertension.
Hypertension affects about one third of the adult population of the world, and its consequences, such as stroke and heart attacks, are enormous public health problems, and the potential advantages of acupuncture over conventional medical therapy include few, if any, of side effects.
Note: Material may have been edited for length and content. For further information, please contact the cited source.
Li M et al. Repetitive Electroacupuncture Attenuates Cold-Induced Hypertension through Enkephalin in the Rostral Ventral Lateral Medulla. Scientific Reports, Published Online October 24 2016. doi: 10.1038/srep35791
Already affecting more than five million Americans older than 65, Alzheimer’s disease is on the rise. In a study published today in the journal BRAIN, neuroscientists used data from the human brain connectome – a publicly available “wiring diagram” of the human brain based on data from thousands of healthy human volunteers – to reassess the findings from neuroimaging studies of patients with Alzheimer’s disease.READ MORE